Lisa K Jennings, PhD founded CirQuest Labs in 2008 as anextension of her successful basic and translational research program
as a faculty member at the University of Tennessee Health Science Center. An internationally recognized leader in anti-platelet and anticoagulant therapies, she has served on numerous industry scientific and clinical development advisory boards. She has been instrumental in assisting industry in the design and implementation of mechanistic studies and clinical trials in the vascular biology field, including CAD, stroke, PAD, inflammatory and metabolic diseases, hematology, and medical device fields.
Dr. Jennings was also Director of the UTHSC Vascular Biology Center of Excellence and Professor of Medicine at the University of Tennessee Health Science Center (UTHSC) in Memphis, Tennessee. She had secondary appointments as Professor in the Departments of Molecular Sciences and Surgery as well as in the Joint Program of Biomedical Engineering at UTHSC and the University of Memphis. She was also the Director of the Tennessee-Arkansas-Mississippi (TAM) Clinical Research Consortium. Currently, she is a Clinical Professor in the Department of Internal Medicine at UTHSC.